Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9K Hold
61
﹤0.01% 1321
2026
Q1
$8K Hold
61
﹤0.01% 1330
2025
Q4
$9K Hold
61
﹤0.01% 1214
2025
Q3
$9K Hold
61
﹤0.01% 1218
2025
Q2
$7K Hold
61
﹤0.01% 1087
2025
Q1
$7K Buy
+61
New +$7.72K ﹤0.01% 1047
2023
Q4
Sell
-10,832
Closed -$1.14M 578
2023
Q3
$1.14M Sell
10,832
-30,629
-74% -$3.43M 0.06% 235
2023
Q2
$5.03M Buy
41,461
+548
+1% +$60.1K 0.26% 112
2023
Q1
$4.45M Buy
+40,913
New +$4.33M 0.24% 123
2019
Q3
Sell
-18
Closed -$2K 964
2019
Q2
$2K Buy
+18
New +$1.94K ﹤0.01% 795

Other funds holding JBTM

CX Institutional's JBTM Position: Q2 2026 in Review

CX Institutional held its JBT Marel (JBTM) position steady in Q2 2026 at 61 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

CX Institutional first reported a position in JBTM in Q2 2019 and has held it in 10 quarters since. The position peaked at $5.03M in Q2 2023. 390 funds tracked by Wall St. Rank hold JBTM as of Q2 2026.

  • CX Institutional held 61 shares of JBT Marel worth $9K as of Q2 2026.
  • CX Institutional left its JBT Marel share count unchanged in Q2 2026.
  • JBT Marel made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1321 holding.
  • CX Institutional first reported a position in JBT Marel in Q2 2019 and has held it in 10 quarters since.
  • CX Institutional's JBT Marel position peaked at $5.03M in Q2 2023.
  • 390 funds tracked by Wall St. Rank held JBT Marel as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.